- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Prostate
Clinical Trial Search
Trial Protocol ID
PRODIGY *RIT*
IRONMAN Registry Sub-Study: PRODIGY: Observational study to describe effectiveness of olaparib in subjects with metastatic castration-resistant prostate cancer who have failed prior treatment with a new hormonal agent and carry selected homologous recombination repair gene mutations
Trial Protocol ID
USOR 21181_ZEN003694-201
Investigator
Mohit Narang, MD
Randomized Phase 2b Study of ZEN003694 in Combination with Enzalutamide versus Enzalutamide Monotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer